This is an old revision of this page, as edited by حسن علي البط (talk | contribs) at 23:16, 27 September 2010. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 23:16, 27 September 2010 by حسن علي البط (talk | contribs)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compoundClinical data | |
---|---|
Other names | Coumamycin |
ATC code |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.164.703 |
Chemical and physical data | |
Formula | C55H59N5O20 |
Molar mass | 1110.08 g/mol g·mol |
3D model (JSmol) | |
SMILES
|
Coumermycin A1 is an aminocoumarin.
References
- Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 19463934, please use {{cite journal}} with
|pmid=19463934
instead. - Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 18473891, please use {{cite journal}} with
|pmid=18473891
instead.
This systemic antibiotic-related article is a stub. You can help Misplaced Pages by expanding it. |
Antibacterials that inhibit nucleic acid (J01E, J01M) | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Antifolates (inhibit bacterial purine metabolism, thereby inhibiting DNA and RNA synthesis) |
| ||||||||||||||||
Quinolones (inhibit bacterial topoisomerase and/or DNA gyrase, thereby inhibiting DNA replication) |
| ||||||||||||||||
Anaerobic DNA inhibitors |
| ||||||||||||||||
RNA synthesis |
| ||||||||||||||||
|